{
  "trial_id": "NCT03735680",
  "trial_group": "cancer",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, gender, tumor type, tumor stage, prior treatments, performance status, liver function, renal function, life expectancy, biopsy confirmation, surgical resection status.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "gender"
        ],
        [
          "Patients receiving pegsitacianine (ONM-100)",
          "biopsy confirmation"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Ethnicity (NIH/OMB)",
        "Race (NIH/OMB)",
        "Region of Enrollment"
      ],
      "remaining_candidate_features": [
        "tumor type",
        "tumor stage",
        "prior treatments",
        "performance status",
        "liver function",
        "renal function",
        "life expectancy",
        "surgical resection status"
      ]
    }
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Tumor Type, Tumor Stage, Liver Function (Child-Pugh score), Life Expectancy,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ]
      ],
      "remaining_reference_features": [
        "Ethnicity (NIH/OMB)",
        "Race (NIH/OMB)",
        "Patients receiving pegsitacianine (ONM-100)"
      ],
      "remaining_candidate_features": [
        "Race/Ethnicity",
        "Tumor Type",
        "Tumor Stage",
        "Liver Function (Child-Pugh score)",
        "Life Expectancy"
      ]
    }
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Tumor type, Tumor stage, Prior cancer treatment, Prior surgery, Performance status, Body Mass Index,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ]
      ],
      "remaining_reference_features": [
        "Ethnicity (NIH/OMB)",
        "Race (NIH/OMB)",
        "Patients receiving pegsitacianine (ONM-100)"
      ],
      "remaining_candidate_features": [
        "Race/Ethnicity",
        "Tumor type",
        "Tumor stage",
        "Prior cancer treatment",
        "Prior surgery",
        "Performance status",
        "Body Mass Index"
      ]
    }
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, race, ethnicity, body mass index (BMI), tumor type, tumor stage, prior cancer treatment, surgical procedure, comorbidities, liver function tests, Child-Pugh score, life expectancy.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Race (NIH/OMB)",
          "race"
        ],
        [
          "Ethnicity (NIH/OMB)",
          "ethnicity"
        ],
        [
          "Patients receiving pegsitacianine (ONM-100)",
          "tumor type"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Region of Enrollment"
      ],
      "remaining_candidate_features": [
        "body mass index (BMI)",
        "tumor stage",
        "prior cancer treatment",
        "surgical procedure",
        "comorbidities",
        "liver function tests",
        "Child-Pugh score",
        "life expectancy."
      ]
    }
  }
}